Congenital generalized lipodystrophy type 3
MONDO:0012923Any congenital generalized lipodystrophy in which the cause of the disease is a mutation in the CAV1 gene.
Also known as: BSCL3, CAV1 congenital generalised lipodystrophy (disease), CAV1 congenital generalized lipodystrophy (disease), CGL3, congenital generalised lipodystrophy (disease) caused by mutation in CAV1, congenital generalized lipodystrophy (disease) caused by mutation in CAV1, Berardinelli-Seip congenital lipodystrophy, type 3, lipodystrophy, Berardinelli-Seip congenital, type 3
4 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Old drug, new hope for right heart failure?
Disease control CompletedThis study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it is safe and can improve heart function and reduce stress on the heart. Participants took either the drug or a placebo to compare effects.
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Rare fat disorder gene hunt: just 2 patients could unlock answers
Knowledge-focused CompletedThis study looked for a new gene that causes hereditary lipodystrophy, a rare disease where people lose body fat and often develop diabetes and heart problems. Researchers studied DNA and cells from 2 patients who had the disease but no known genetic cause. The goal was to find t…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC